Status
Conditions
Treatments
About
The goal of this clinical trial is to evaluate and prevent fluid overload in critically ill, mechanically ventilated children. The main questions it aims to answer are:
Researchers will compare the effects of strict adherence to the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) guidelines regarding fluid balance (i.e. restricting fluid intake and preventing a positive fluid balance) to current local practice.
From the start to the end of invasive mechanical ventilation participants will be treated according to local practice or with the strict aim to prevent a positive fluid balance. Aiming to prevent a positive fluid balance, if this is possible given the clinical context, is at descretion of the attending physician. Minimal caloric intake requirements must be met.
Participants are studied for ten days during invasive mechanical ventilation or until discharge from the intensive care
Full description
Objectives
Study Design
Type: Multicenter prospective study with a before-after design, continuous recruitment, and single measurements.
Groups:
Treatment
Feeding Enteral nutrition starts within 24-48 hours unless contraindicated, with caloric intake reaching 100% of resting energy expenditure by day 7 and protein intake exceeding 1.5 g/kg/day.
Diuretics The choice and route of diuretics will be at the treating physician's discretion.
Duration of Intervention Start: Onset of mechanical ventilation. End: End of mechanical ventilation.
Study Procedures Children will have routine blood samples taken daily during invasive mechanical ventilation (IMV), which align with standard clinical diagnostics. Body weight will be measured at admission, on day 3, and before extubation. Data on fluid intake, feeding, medication, and urine output will be gathered prospectively in the electronic patient dossier (EPD).
Adverse Events All adverse events will be recorded, with serious adverse events (SAEs) reported to the sponsor promptly.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
90 participants in 2 patient groups
Loading...
Central trial contact
Michiel Schwerzel, MSc; Joris Lemson, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal